Learning objectives
At the end of the training activity the student should have acquired knowledge and skills related to the economic analysis of health interventions in the following terms:
1. Understanding the mechanisms underlying the health economy, methods of economic analysis and therapeutic drug and health technologies monitoring (Knowledge and understanding)
2. Acquire the ability to correctly apply the main techniques of economic analysis in the health sector and be able to detect the health and non-health costs (ability to apply knowledge and understanding)
3. Link the different topics dealt with each other (Learning skills).
Prerequisites
No one
Course unit content
• Health demand, regulation of pharmaceutical and medical devices market, technological innovation and evolution of health spending.
• Economic analysis for the governance of health systems: general concepts and definitions.
• Pharmacoeconomics: the dimensions of the therapeutic value of a pharmacological treatment, criteria evaluation for pharmacoeconomic, the main analysis techniques.
• HTA and governance of medical devices.
• Pharmacist’s role in pharmacoeconomics: some ”real world” examples in hospital setting.
Full programme
Evolution of health-care expenditure.
Pharmaceutical and device market and regulatory policy.
Health economics principles.
Health-and non-health care costs.
Risk management and pharmacoeconomic.
Main analysis techniques (cost minimization analysis, cost-effectiveness analysis, cost utility, cost-benefit analysis); HTA; health system database (AFO, FED/DiMe).
Budgeting and forecasting system: some examples on “real world” data (i.e. breast reconstruction with one-step approach; economic impact of biosimilar in Italy).
Bibliography
Link from institutional sites (FDA, EMA, AIFA) recommended during the lessons
Teaching methods
Oral frontal lectures in a dialogical form and exercises centered on case-histories of well-known or widely used drugs (or device) with particular problems encountered during the professional activity by the teacher concerning the subject within the pharmaceutical industry. A series of slides on crucial topics of the program is made available only to students of the course through reserved access on the site elly.saf.unipr.it
Assessment methods and criteria
The assessment of the achievement of the objectives set by the course through assessment of learning that includes a written test structured in 10 questions closed multiple-choice. Each question involves the acquisition of 3/30 in the case of an exact response, 0/30 in the case of a non-response or incorrect.
The duration of the written test is equal to 30 minutes and is evaluated with a scale of 0-10. 6 correct response to pass the examination
The results of the examination are published on the Esse3 portal within 3 days from the exam date. Students can view the exam by appointment with the teacher.
st is equal to 30 minutes and is evaluated with a scale of 0-30.
The results of the examination are published on the Esse3 portal within 3 days from the exam date. Students can view the exam by appointment with the teacher.
Other information
The teacher can be contacted via e-mail (azanardi@ao.pr.it)
